Efficacy of the BNT162b2 Vaccine Against Omicron Infection in Children 5 to 11 Years of Age
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effectiveness of BNT162b2 Vaccine against Omicron in Children 5 to 11 Years of Age
N. Engl. J. Med 2022 Jul 20;[EPub Ahead of Print], SHX Tan, AR Cook, D Heng, B Ong, DC Lye, KB TanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.